Dashboard
Manage Tickers

INMD InMode Ltd.

Nasdaq inmodemd.com


$ 16.05 $ 0.00 (0 %)    

Tuesday, 21-Oct-2025 17:12:04 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 610.86 $ -0.16 (-0.03 %)
DIA $ 469.35 $ 2.20 (0.47 %)
SPY $ 671.30 $ -0.01 (0 %)
TLT $ 92.05 $ 0.45 (0.49 %)
GLD $ 379.20 $ -25.91 (-6.43 %)
$ 16.01
$ 16.07
$ 15.94 x 1
$ 16.07 x 189
$ 15.96 - $ 16.25
$ 13.14 - $ 19.85
453,729
na
1.11B
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
The U.S. FDA Is Making Consumers, Patients...
10/15/2025 15:10:20

https://www.fda.gov/medical-devices/safety-communications/potential-risks-certain-uses-radiofrequency-rf-microneedling-fda-safe...

canaccord-genuity-maintains-hold-on-inmode-raises-price-target-to-16
Canaccord Genuity Maintains Hold on InMode...
10/10/2025 12:47:30

Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and raises the price target from $14 to ...

needham-reiterates-hold-on-inmodeto-hold
Needham Reiterates Hold on InModeto Hold
10/10/2025 10:08:47

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) from Hold to Hold.

inmode-affirms-fy2025-sales-guidance-of-365000m-375000m-vs-370991m-est
InMode Affirms FY2025 Sales Guidance of $3...
10/09/2025 11:20:56

inmode-sees-q3-sales-92500m-93000m-vs-85873m-est
InMode Sees Q3 Sales $92.500M-$93.000M vs ...
10/09/2025 11:20:44

doma-perpetual-capital-management-urges-inmode-board-to-approve-two-10-buybacks-in-q4-2025-and-q1-2026-citing-duty-to-return-capital-to-shareholders
DOMA Perpetual Capital Management Urges In...
09/09/2025 12:20:54

Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026Maintains Board Has Le...

needham-reiterates-hold-on-inmodeto-hold
Needham Reiterates Hold on InModeto Hold
07/30/2025 16:38:47

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) from Hold to Hold.

barclays-maintains-overweight-on-inmode-lowers-price-target-to-21
Barclays Maintains Overweight on InMode, L...
07/30/2025 13:17:26

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $24 to $21.

inmode-lowers-fy2025-adj-eps-guidance-from-164-168-to-155-159-vs-169-est-affirms-fy2025-sales-guidance-of-365000m-375000m-vs-387675m-est
InMode Lowers FY2025 Adj EPS Guidance from...
07/30/2025 11:33:10

InMode (NASDAQ:INMD) lowers FY2025 Adj EPS guidance from $1.64-$1.68 to $1.55-$1.59 vs $1.69 analyst estimate. Affirms FY2025 s...

inmode-q2-adj-eps-047-beats-043-estimate-sales-95602m-miss-98810m-estimate
InMode Q2 Adj. EPS $0.47 Beats $0.43 Estim...
07/30/2025 11:01:29

InMode (NASDAQ:INMD) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.43 by 9.56 ...

Core News & Articles
Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

what-to-expect-from-inmodes-earnings
What to Expect from InMode's Earnings
07/29/2025 21:02:23

canaccord-genuity-maintains-hold-on-inmode-maintains-15-price-target
Canaccord Genuity Maintains Hold on InMode...
07/11/2025 14:31:50

Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and maintains $15 price target.

inmode-sees-q2-revenue-954m-955m-cuts-2025-revenue-outlook-from-395m-405m-to-365m-375m
InMode Sees Q2 Revenue $95.4M-$95.5M; Cuts...
07/10/2025 11:06:42

inmode-announces-health-canada-certification-of-igniterf-platform-with-new-quantumrf-tech
InMode Announces Health Canada Certificati...
05/20/2025 13:20:32

doma-perpetual-capital-management-urges-inmode-board-to-resume-stock-buyback-replace-ceo
DOMA Perpetual Capital Management Urges In...
05/09/2025 12:28:35

Believes the Board Should Immediately Resume and Accelerate BuybacksAsserts Board Should Remove Moshe Mizrahy as CEO of the Com...

inmode-awarded-injunction-and-damages-for-counterfeit-sales-of-morpheus8-radio-frequency-microneedling-devices-and-needle-cartridges
InMode Awarded Injunction And Damages For ...
05/06/2025 12:09:59

barclays-maintains-overweight-on-inmode-lowers-price-target-to-24
Barclays Maintains Overweight on InMode, L...
04/30/2025 15:10:31

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $29 to $24.

ubs-maintains-neutral-on-inmode-lowers-price-target-to-1625
UBS Maintains Neutral on InMode, Lowers Pr...
04/29/2025 14:44:12

UBS analyst Danielle Antalffy maintains InMode (NASDAQ:INMD) with a Neutral and lowers the price target from $19 to $16.25.

btig-downgrades-inmode-to-neutral
BTIG Downgrades InMode to Neutral
04/29/2025 13:20:04

BTIG analyst Sam Eiber downgrades InMode (NASDAQ:INMD) from Buy to Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION